Phase II study of intensified rituximab induction and maintenance for low grade B cell lymphoma.
Nagai H, Shimomura T, Takeuchi M, Hanada S, Komeno T, Sunami K, Hidaka M, Yano T, Kitano K, Yoshida I, Inoue N, Saito A, Horibe K, Motitani S, Ichihara S, Watanabe T, Sawamura M.
Nagai H, et al.
Leuk Lymphoma. 2017 Dec;58(12):2845-2851. doi: 10.1080/10428194.2017.1319054. Epub 2017 May 16.
Leuk Lymphoma. 2017.
PMID: 28509595
Clinical Trial.